M&A Deal Summary |
|
|---|---|
| Date | 2025-11-06 |
| Target | IRRAS |
| Sector | Medical Products |
| Buyer(s) | ClearPoint Neuro |
| Deal Type | Add-on Acquisition |
| Deal Value | 5M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 115 |
| Revenue | 31M USD (2024) |
ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. ClearPoint Neuro provides both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ClearPoint Neuro was incorporated in 1998 and is headquartered in Solana Beach, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |